Efficacy and safety of erlotinib combined with bevacizumab in the treatment of non-small cell lung cancer: A systematic review and meta-analysis.
Medicine 2020 Jan 99 (3): e18771.
Zhou Kenan, Zhao Shishun, Guo Wenlai, Ding L
Four common vascular endothelial growth factor polymorphisms (-2578C>A, -460C>T, +936C>T, and +405G>C) in susceptibility to lung cancer: a meta-analysis.
PloS one 2013 8 (10): e75123.
Lin Ling, Cao Kejian, Chen Wenhu, Pan Xufeng, Zhao He